Compare NBP & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBP | DRDB |
|---|---|---|
| Founded | 2014 | 2024 |
| Country | United States | United States |
| Employees | 32 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 320.5M |
| IPO Year | N/A | N/A |
| Metric | NBP | DRDB |
|---|---|---|
| Price | $2.64 | $10.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 806.7K | 437.0K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $597.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.44 | $9.96 |
| 52 Week High | $5.19 | $10.55 |
| Indicator | NBP | DRDB |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 54.43 |
| Support Level | N/A | $10.42 |
| Resistance Level | $3.80 | $10.55 |
| Average True Range (ATR) | 0.24 | 0.01 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 18.97 | 41.67 |
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
Roman DBDR Acquisition Corp II is a blank check company.